Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00997438 · ClinicalTrials.gov registry record · Phase 1
Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis
A Phase 1 study, sponsored by Portland VA Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 69
- Enrollment target
NCT00997438: Completed Phase 1 study, sponsored by Portland VA Medical Center.
NCT00997438 is a Phase 1 study that has completed, run by Portland VA Medical Center. The registered enrollment target is 69 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (15% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00997438, a Phase 1 study, has completed, sponsored by Portland VA Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 69 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about how the antioxidant, lipoic acid, works in the body and how it may help in the management of relapsing remitting and secondary progressive multiple sclerosis. This study will compare how subject's and healthy volunteers bodies absorb and break down the supplement. This information may help in developing new therapies.
Primary Outcome
Plasma concentration of LA
Interventions
- DIETARY_SUPPLEMENT Lipoic Acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-12 |
| Phase | Phase 1 |
What the finished NCT00997438 record still lists
NCT00997438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (15% higher).
The record links to 0 conditions, and to 1 intervention - of which Lipoic Acid is the first listed.
NCT00997438 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00997438 about?
NCT00997438 is a clinical study titled "Defining the Anti-inflammatory Role of Lipoic Acid in Multiple Sclerosis". The purpose of this study is to learn about how the antioxidant, lipoic acid, works in the body and how it may help in the management of relapsing remitting and secondary progressive multiple sclerosis. This study will compare how subject's and healthy volunteers bodies absorb and break down the sup...
What is the current status of trial NCT00997438?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 69 participants. The study started on 2010-08. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00997438?
The interventions under investigation include: Lipoic Acid (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00997438?
This trial is sponsored by Portland VA Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00997438's enrollment target sits among peer trials
69 774th of 2000 higher than 1,225 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia